1-13 of 13
Yun Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Low Intensity Daratumumab to Treat Rersistent/Recurrent Minimal Residual Disease in Multiple Myeloma

Lingzhi Yan, Xiaolan Shi, Jing Wang, Song Jin, Ying Yao, Panfeng Wang, Jingjing Shang, Yingying Zhai, Shuang Yan, Yun Xu, Jiajia Meng, Weiqin Yao, Xiao Ma, Chengcheng Fu, Depei Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4750.
https://doi.org/10.1182/blood-2024-205595
Published: 2024
Journal Articles

11q Gain with t(11;14) or Alone Were Associated with Poor Prognosis in Newly-Diagnosed Multiple Myeloma Patients By SNP-Array Analysis and FISH

Jiao Lu, Chengcheng Fu, Jinlan Pan, Zhao Zeng, Jingjing Shang, Song Jin, Lingzhi Yan, Zhiyu Zhang, Hongying You, Xiaolan Shi, Shuang Yan, Weiqin Yao, Jing Wang, Yun Xu, Chunxiao Wu, Wanhui Yan, Hongmiao Shen, Yue Huang, Xin Xiang, Qian Wang, Zhi Yan, Xingyue Wu, Qinrong Wang, Lijun Wen, Suning Chen, Depei Wu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1968.
https://doi.org/10.1182/blood-2023-184870
Published: 2023
Journal Articles

A Universal CRISPR/Cas9n-Mediated Genome Editing Approach for ELANE -Related Severe Congenital Neutropenia

Masoud Nasri, Malte Ulrich Ritter, Perihan Mir, Benjamin Dannenmann, Masako Monika Kaufmann, Yun Xu, Natalia Borbaran-Bravo, Maksim Klimiankou, Claudia Lengerke, Cornelia Zeidler, Toni Cathomen, Karl Welte, Julia Skokowa
Journal: Blood
Blood (2023) 142 (Supplement 1): 932.
https://doi.org/10.1182/blood-2023-181678
Published: 2023
Journal Articles

Disease Modeling of Severe Congenital Neutropenia Using CRISPR/Cas9 Gene Correction or Knockout of ELANE in Patients Derived Induced Pluripotent Stem Cells

Masoud Nasri, MSc, Benjamin Dannenmann, Perihan Mir, Malte U Ritter, Diana Amend, Yun Xu, Maksim Klimiankou, Cornelia Zeidler, Karl Welte, Julia Skokowa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 434.
https://doi.org/10.1182/blood-2019-129991
Published: 2019
Journal Articles

LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis

Tatsuya Morishima, Ann-Christin Krahl, Masoud Nasri, Yun Xu, Narges Aghaallaei, Betül Findik, Maksim Klimiankou, Malte Ritter, Marcus D. Hartmann, Christian Johannes Gloeckner, Sylwia Stefanczyk, Christian Lindner, Benedikt Oswald, Regine Bernhard, Karin Hähnel, Ursula Hermanutz-Klein, Martin Ebinger, Rupert Handgretinger, Nicolas Casadei, Karl Welte, Maya Andre, Patrick Müller, Baubak Bajoghli, Julia Skokowa
Journal: Blood
Blood (2019) 134 (14): 1159–1175.
https://doi.org/10.1182/blood.2019000095
Published: 2019
Includes: Supplemental data
Journal Articles

A Method to Fluorescently Label the CRISPR/Cas9-gRNA RNP Complexes Enables Enrichment of Clinical-Grade Gene-Edited Primary Hematopoietic Stem Cells and iPSCs

Masoud Nasri, Perihan Mir, Benjamin Dannenmann, Diana Amend, Yun Xu, Anna Solovyeva, Sylwia Stefanczyk, Maksim Klimiankou, Cornelia Zeidler, Lothar Kanz, Karl Welte, Julia Skokowa, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1108.
https://doi.org/10.1182/blood-2018-99-114844
Published: 2018
Journal Articles

Bortezomib, Liposome Doxorubicin and Dexamethasone (PDd) Is Superior in Safety and Not Inferior in Efficiency to Bortezomib, Doxorubicin and Dexamethasone (PAd) As Induction Therapy in New-Diagnosed Multiple Myeloma Patients: An Interim Report from China's Multicenter Study

Song Jin, Yun Xu, Jin Zhou, Jingjing Shang, Lingzhi Yan, Chengcheng Fu, Depei Wu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5433.
https://doi.org/10.1182/blood.V130.Suppl_1.5433.5433
Published: 2017
Journal Articles

Application of the Conditioning Regimen with Busulfan and Cyclophosphamide in Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Yun Xu, Ying Yao, Weiqin Yao, Song Jin, Lingzhi Yan, Jingjing Shang, Chengcheng Fu, Depei Wu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5517.
https://doi.org/10.1182/blood.V130.Suppl_1.5517.5517
Published: 2017
Journal Articles

Evaluating Prognostic Value of Patients with Newly Diagnosed Multiple Myeloma By Serum Free Light Chain κ/λ Ratio in Combination with LDH

Chengcheng Fu, Panfeng Wang, Feiran Gong, Jiazi Zhou, Ying Yao, Yun Xu, Yang Xu, Huirong Chang, Depei Wu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5623.
https://doi.org/10.1182/blood.V128.22.5623.5623
Published: 2016
Journal Articles

Retrospective Analysis of 111 Cases of Multiple Myeloma Treated with Autologous Hematopoietic Stem Cell Transplantation

Chengcheng Fu, Yun Xu, Juan Wang, Jin Zhou, Ling Ma, Shuang Yan, Panfeng Wang, Ying Yao, Song Jin, Lingzhi Yan, Depei Wu, MDPhD
Journal: Blood
Blood (2016) 128 (22): 5833.
https://doi.org/10.1182/blood.V128.22.5833.5833
Published: 2016
Journal Articles

Retrospective Study of the Efficacy and Safety of Treatment with Subcutaneous Injection of Bortezomib in De Novo Patients with MM

Chengcheng Fu, Ling Ma, Shuang Yan, Hui Liu, Yun Xu, Wu Depei, MD
Journal: Blood
Blood (2015) 126 (23): 5074.
https://doi.org/10.1182/blood.V126.23.5074.5074
Published: 2015
Journal Articles

Anti-Proliferative Effect of Rapamycin on Human T Cell Leukemia Cell Line Jurkat by Cell Cycle Arrest and Telomerase Inhibition.

Yanmin Zhao, M.D., Yun Xu, M.D., Jianping Lan, M.D., Ph.D., Yuanyuan Zhu, M.D., Ph.D., He Huang, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4285.
https://doi.org/10.1182/blood.V110.11.4285.4285
Published: 2007
Journal Articles

Effects of Celecoxib on Human Acute Promyelocytic Leukemia Cell Line and Its Mechanism.

Yun Xu, M.D., Ph.D., He Huang, MD, PhD, Yanmin Zhao, M.D., Fenfang Zeng, M.D., Qian Zhou, M.D.
Journal: Blood
Blood (2007) 110 (11): 2851.
https://doi.org/10.1182/blood.V110.11.2851.2851
Published: 2007